Lamark Biotech funding, investors and company details

Lamark Biotech is an emerging Healthcare - Nutrition startup from Ahmedabad, working in the space of Developing thermostable biologics to enhance the stability, accessibility, and affordability of protein-based medicines.. Founded by Vaibhav Bhatia.

Company: Lamark Biotech Private Limited
Sector: Healthcare - Nutrition
Location: Ahmedabad
Founders: Vaibhav Bhatia

Company overview

The Ahmedabad-based biotech startup Lamark Biotech was established in 2018 with the goal of creating thermostable biologics using its exclusive ProteoStrongTM platform, which increases the stability of protein-based medications such as insulin, monoclonal antibodies, and enzymes and lessens the requirement for rigorous cold-chain storage. InsulinStrong, its flagship product, seeks to reduce costs and increase accessibility, particularly in low-resource environments, by offering insulin that is effective for extended periods of time at room temperature. In a recent pre-Series A financing, the firm raised ₹6.5 crore to grow its biologics pipeline, start clinical studies, improve its patent portfolio, and advance research and development.

Funding rounds

Latest round (Pre-Series A): ₹6.50 Cr. ($ 0.74 Mn), 2025-07-01. Investors: IAN Alpha Fund, Vinayender Tull, Nita Roy, Venkataraman KNK